A clinical trial to compare the effects of Unani research drug Cap Nazla with allopathic drug Tablet Levocetirizine in patients with Common cold
Phase 3
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2022/11/047772
- Lead Sponsor
- Central Council for Research in Unani Medicine (CCRUM), New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of either sex in the age group of 18-65
2. Patients of Nazla Haar presenting the following sign and symptoms:
Nasal irritation/ Nasal Itching
Redness of Face
Redness of Eyes
Discharge of yellowish secretion of thin
consistency
Exclusion Criteria
1. Known cases of Acute or Chronic lower respiratory tract infection like pneumonia, Bronchitis, Asthma and Bronchiectasis.
2. Fever > 100oF.
3. Known cases of any other acute illness.
4. Known cases of long standing chronic illnesses.
5. Pregnant and lactating women.
6. History of Addiction (smoking, alcohol)
7. History of hepatic, renal disorders, Diabetes Mellitus, Hypertension, or any other ailment needing long term therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method